Rivaroxaban
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Rivaroxaban and local guidelines before prescribing.
Mechanism
Direct factor Xa inhibitor.
Uses
Stroke prevention in non-valvular AF, VTE treatment and prophylaxis, secondary prevention in coronary and peripheral artery disease.
Dosing
- Rivaroxaban AF stroke prevention | Usually 20 mg orally daily with food; 15 mg daily with food in relevant renal impairment by CrCl.
Cardiology: Cardiac Arrhythmias › 5.42 Two-Column Drug and Dose Table - Rivaroxaban 15 mg twice daily for 21 days, then 20 mg once daily.
Respiratory: Emergencies - Rivaroxaban PE | 15 mg twice daily for 21 days, then 20 mg once daily with food.
Respiratory: Emergencies - Rivaroxaban VTE treatment | 15 mg twice daily for 21 days, then 20 mg daily with food; 10 mg daily option for extended prevention.
Respiratory: Pulmonary Vascular Disease
4 more dose entries from the chapters
- Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily for AF - with food at 15 mg and 20 mg doses), edoxaban (once daily).
Haematology: Anatomy Physiology and Pharmacology - Rivaroxaban 15 mg twice daily for 21 days, then 20 mg once daily (with food).
Haematology: Haemostasis and Thrombosis - Rivaroxaban (Xa inhibitor) | AF: 20 mg once daily with food (15 mg if CrCl 15–49). VTE: 15 mg twice daily for 21 days, then 20 mg daily
Haematology: Haemostasis and Thrombosis - Statin (atorvastatin 80 mg) and antiplatelet ( clopidogrel 75 mg is first choice); in selected patients, low-dose rivaroxaban 2.5 mg twice daily with aspirin (COMPASS regimen).
Surgery: Vascular surgery
Side effects
Bleeding, anaemia, nausea, abnormal LFT.
Interactions
Strong CYP3A4 and P-gp inhibitors or inducers; avoid other anticoagulants.
Contraindications and cautions
Active bleeding, mechanical valve, severe liver disease
Monitoring
Renal function, Hb
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid if CrCl below 15
Overdose and reversal
Andexanet alfa or prothrombin complex concentrate
Special advice
Take with food for 15 and 20 mg doses; reduce or avoid in renal impairment; andexanet alfa reversal.
More from the textbook: uses, cautions and other points
- Where drugs act - aspirin (COX-1), clopidogrel/prasugrel/ticagrelor (P2Y12), warfarin (vitamin K-dependent factors II, VII, IX, X), heparins (antithrombin), apixaban/rivaroxaban/edoxaban (Xa), dabigatran (thrombin), alteplase/tenecteplase (plasminogen).
Cardiology: Anatomy Physiology and Pharmacology - Factor Xa inhibitors - apixaban (twice daily), rivaroxaban (once daily with food in AF), edoxaban (once daily).
Cardiology: Anatomy Physiology and Pharmacology - Lifelong warfarin (VKA) . DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) must never be used - they caused excess valve thrombosis and stroke in trials.
Cardiology: Valvular heart disease › 4.34 Anticoagulation and Valves - First line (NICE NG158) for confirmed proximal DVT or PE — apixaban or rivaroxaban (no LMWH lead-in needed).
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - First-line treatment | Apixaban or rivaroxaban
Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease - Most patients: A DOAC - apixaban or rivaroxaban (no heparin lead-in needed), or LMWH then dabigatran or edoxaban.
Respiratory: Pulmonary Vascular Disease
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Valvular heart disease (1 mention)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Cardiology: Venous Thromboembolism and Pulmonary Vascular Disease (4 mentions)
- Respiratory: Emergencies (2 mentions)
- Respiratory: Pulmonary Vascular Disease (2 mentions)
- Respiratory: Sleep and Breathing (Complete) (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (4 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (3 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Haemostasis and Thrombosis (8 mentions)
- Oncology: Emergencies (2 mentions)
- Rheumatology: Connective tissue diseases (1 mention)
- Surgery: Surgical principles and perioperative care (3 mentions)
- Surgery: Vascular surgery (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (2 mentions)
- Acute Medicine: Acute chest pain, breathlessness, collapse and blood gases (1 mention)
- Acute Medicine: The acute medical take (3 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (4 mentions)
- Integrated respiratory chapter (4 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (1 mention)